Efficacy and Safety of Minocycline in Patients With Moderate to Severe Acute Ischemic Stroke
Status:
Not yet recruiting
Trial end date:
2024-10-01
Target enrollment:
Participant gender:
Summary
The aim of this study was to evaluate the efficacy and safety of Minocycline versus placebo
in the treatment of patients with moderate to severe acute ischemic stroke.